Atanasio
Pandiella Alonso
Universitat Pompeu Fabra
Barcelona, EspañaPublicacions en col·laboració amb investigadors/es de Universitat Pompeu Fabra (4)
2022
-
Therapy-Induced Senescence Enhances the Efficacy of HER2-Targeted Antibody-Drug Conjugates in Breast Cancer
Cancer research, Vol. 82, Núm. 24, pp. 4670-4679
-
mTOR Inhibition and T-DM1 in HER2-Positive Breast Cancer
Molecular Cancer Research, Vol. 20, Núm. 7, pp. 1108-1121
2021
-
Preclinical and clinical characterization of fibroblast-derived neuregulin-1 on trastuzumab and pertuzumab activity in HER2-positive breast cancer
Clinical Cancer Research, Vol. 27, Núm. 18, pp. 5096-5108
2017
-
Defective cyclin B1 induction in trastuzumab-emtansine (T-DM1) acquired resistance in HER2-positive breast cancer
Clinical Cancer Research, Vol. 23, Núm. 22, pp. 7006-7019